Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Celldex Therapeutics Announces Proposed Public Offering of Common Stock
-
TD Cowen Starts Celldex Therapeutics (CLDX) at Outperform; 'barzolvolimab has blockbuster potential'
-
Form SC 13G/A Celldex Therapeutics, Filed by: Cowen Financial Products LLC
-
Form SC 13G/A Celldex Therapeutics, Filed by: Cowen Financial Products LLC
-
Form SC 13G Celldex Therapeutics, Filed by: Cowen Financial Products LLC
-
Cowen Downgrades Celldex Therapeutics (CLDX) to Market Perform
-
Celldex to Report Fourth Quarter and Year-End 2017 Business/Financial Results and Present at Upcoming Investor Conference
-
Celldex Therapeutics Announces Upcoming Investor Presentations and 2016 Year-End Call
-
Pre-Open Stock Movers 06/06: (VBLT) (YGE) (ONTY) Higher; (DNAI) (ADMP) (MRTX) Lower (more...)
-
Celldex Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference
-
Trading Radar for 2/25: Baidu (BIDU), Best Buy (BBY), Sears (SHLD), Weight Watchers (WTW) Report
-
Cowen Cuts Price Target on Celldex (CLDX) Following 2Q and Clinical Update
-
Celldex Therapeutics (CLDX) PT Bumped to $34 at Cowen Amid ReACT Study
-
Streetinsider.com's Hot Lunchtime Reads 11/10: (TWTR) (HIMX) (SVU) (AGU)
-
Notable Analyst Rating Changes 9/26: (UA) (LNKD) (MO) Upgraded; (EAC) (SDRL) (BBRY) Downgraded
-
Pre-Open Stock Movers 9/26: (JNS) (NKE) (MU) Higher; (ACRX) (FINL) (BBRY) Lower (more...)
-
Cowen Starts Celldex Therapeutics (CLDX) at Outperform
-
Unusual 11 Mid-Day Movers 03/03: (XGTI) (VIMC) (PLUG) Higher; (QIWI) (LXFT) (YNDX) Lower